Lifei Xiaoji Wan Treatment's of Early-stage NSCLC and Its Impact on the Tumor Microenvironment

NCT06387134 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Early Stage Lung Adenocarcinoma

Interventions

DRUG: Lifei Xiaoji Wan
DRUG: Conventional treatment with Western medicine

Sponsor

Henan University of Traditional Chinese Medicine